Clinical Trial Update: A Study in Healthy Male Volunteers to Investigate Different Doses of a New Drug for the Treatment of Metabolic Diseases [Phase 1]

View source ↗

Summary

Phase 1 study in healthy male volunteers tested different doses of a new drug for metabolic diseases and the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Snippet

Sponsor: Sirtris, a GSK Company | Conditions: Diabetes Mellitus, Type 2 | Phase 1 | Status: COMPLETED